Time-course of quantitative urinary leukocytes and bacteria counts during antibiotic therapy in women with symptoms of urinary tract infection

Clinica Chimica Acta

Volumn 379, Issue 1-2, 2007, Pages 36-41

  Ottiger, Cornelia ^a   Schaer, Gabriel ^a   Huber, Andreas R ^a  

^a CANTONAL HOSPITAL AARAU   (Switzerland)

Author keywords

Antibiotic; Bacteria; Flow cytometry; KOVA cell chamber; Leukocytes; UF 100; Urinary tract infection

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; COTRIMOXAZOLE; NORFLOXACIN;

ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL COUNT; CLINICAL ARTICLE; DISEASE COURSE; FEMALE; FLOW CYTOMETRY; FOLLOW UP; HUMAN; HUMAN CELL; LEUKOCYTE COUNT; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TREATMENT OUTCOME; URINALYSIS; URINARY TRACT INFECTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIURIA; COLONY COUNT, MICROBIAL; FEMALE; FEMALE UROGENITAL DISEASES; FLOW CYTOMETRY; HUMANS; LEUKOCYTE COUNT; MIDDLE AGED; TREATMENT OUTCOME; URINARY TRACT INFECTIONS;

BACTERIA (MICROORGANISMS);

EID: 33847643170     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2006.11.023     Document Type: Article

References (23)

1. Foxman B. Recurring urinary tract infection: incidence and risk factors. Am J Public Health 80 (1990) 331-333
2. Brauner A., Jacobson S.H., and Kuhn I. Urinary Escherichia coli causing recurrent infections-a prospective follow-up of biochemical phenotypes. Clin Nephrol 38 (1992) 318-323
3. Mysorekar I.U., and Hultgren S.J. Mechanisms of uropathogenic Escherichia coli persistence and eradication from the urinary tract. PNAS 103 (2006) 14170-14175
4. Warren J.W., Abrutyn E., Hebel R.J., Johnson J.R., Schaeffer A.J., and Stamm W.E. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Clin Infect Dis 29 (1999) 745-758
5. Nys S., van Merode T., Bartelds A.I., and Stobberingh E.E. Urinary tract infections in general practice patients: diagnostic tests versus bacteriological culture. J Antimicrob Chemother 57 (2006) 955-958
6. Kripke C. Duration of therapy for women with uncomplicated UTI. Am Fam Phys 72 (2005) 2219
7. Arione R., and Fontana P. Single-dose treatment of lower urinary tract infections with fosfomycin trometamol: preliminary experiences. Chemioterapia 6 (1987) 295-298
8. Preston A., O'Donell T., and Phillips C.A. Screening for urinary tract infections in a gynaecological setting: validity and cost-effectiveness of reagent strips. Br J Biomed Sci 56 (1999) 253-257
9. Jellheden B., Norrby R.S., and Sandberg T. Symptomatic urinary tract infection in women in primary health care. Bacteriological, clinical and diagnostic aspects in relation to host response to infection. Scand J Prim Health Care 14 (1996) 122-128
10. Bolann B.J., Thue G., and Sandberg S. Urine analysis and decision-making on cystitis in general practice. Scand J Clin Lab Invest 64 (2004) 729-735
11. Winkel P., Statland B.E., and Jorgensen K. Urine microscopy, an ill-defined method, examined by a multifactorial technique. Clin Chem 20 (1974) 436-439
12. Norrby S.R. How adequate are the new guidelines on clinical evaluation of bacteriological outcome in uncomplicated UTI?. Int J Antimicrob Agents 11 (1999) 183-184 [discussion 213-216]
13. Fenili D., and Pirovano B. The automation of sediment urinalysis using a new urine flow cytometer (UF-100). Clin Chem Lab Med 36 (1998) 909-917
14. Delanghe J.R., Kouri T.T., Huber A.R., Hannemann-Pohl K., Guder W.G., Lun A., et al. The role of automated urine particle flow cytometry in clinical practice. Clin Chim Acta 301 (2000) 1-18
15. Regeniter A., Haenni V., Risch L., Köchli H.-P., Colombo J.-P., Frei R., et al. Urine analysis performed by flow cytometry: reference range determination and comparison to morphological findings, dipstick chemistry and bacterial culture results - a multicenter study. Clin Nephrol 55 (2001) 384-392
16. Ottiger C., and Huber A.R. Quantitative urine particle analysis: Integrative approach for the optimal combination of automation with UF-100 and microscopic review with KOVA cell chamber. Clin Chem 49 (2003) 617-623
17. European Confederation of Laboratory Medicine (ECLM). European urinalysis guidelines. Scand J Clin Lab Invest 60 Suppl 231 (2000) 1-96
18. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial and susceptibility testing. Fourteenth informational supplement (2004), NCCLS, Wayne, Pa M100-S14
19. Koken T., Aktepe O.C., Serteser M., Samli M., Kahraman A., and Dogan N. Determination of cut-off values for leucocytes and bacteria for urine flow cytometer (UF-100) in urinary tract infections. Int Urol Nephrol 34 (2002) 175-178
20. Stamm W.E., McKevitt M., Roberts P.L., and White N.J. Natural history of recurrent urinary tract infections in women. Rev Infect Dis 13 (1991) 77-84
21. Arione R., and Fontana P. Single-dose treatment of lower urinary tract infections with fosfomycin trometamol: preliminary experiences. Chemioterapia 6 (1987) 295-298
22. Rudenko N., and Dorofeyev A. Prevention of recurrent lower urinary tract infections by long-term administration of fosfomycin trometamol. Double blind, randomized, parallel group, placebo controlled study. Arzneimittelforschung 55 (2005) 420-427
23. Drugeon H., Veyries M.L., Levacher M., et al. Antibacterial activity of urine after administration of ofloxacin for 5 days. Therapies 55 (2000) 691-697